Understanding Opisthotonus: A Dystonic Reaction to Neuroleptic Drugs

Opisthotonus is a severe dystonic reaction that can occur as a result of taking neuroleptic drugs such as phenothiazines, butyrophenones, metoclopramide, and even atypical antipsychotic agents like olanzapine. It is characterised by retrocollis, arching of the back, internal rotation of the arms, and extension of the elbows. This extreme dystonic reaction can also be seen in other neurological situations such as tetanus, hypoxic-ischaemic brain injury, and strychnine poisoning.

Decorticate posturing is another neurological condition characterised by arm flexion and inward turning, extended lower limbs. Decerebrate rigidity, on the other hand, results from a midbrain lesion and is manifest by an exaggerated extensor posture of all four limbs. Anterocollis is forward flexion of the head and neck, which is different from the extensor posture seen in opisthotonus. Chorea is another abnormal involuntary movement characterised by brief, abrupt, irregular, unpredictable, non-stereotyped movements.

In conclusion, understanding opisthotonus and its characteristics is crucial in identifying and managing dystonic reactions to neuroleptic drugs.

Preventing Misplacement of Nasogastric Tubes

The misplacement of a nasogastric tube (NG) in the lungs can lead to fatal consequences. To prevent such never-events, the National Patient Safety Agency (NPSA) and Medical Protection Society (MPS) have suggested methods for ensuring correct placement. Between 2005 and March 2011, the NPSA received reports of 21 deaths and 79 cases of harm caused by misplaced NG tubes.

The first step in confirming correct placement is to test the gastric aspirate with pH indicator paper. A pH reading between 1 and 5.5 is considered confirmatory evidence of correct placement. If there is any doubt, an appropriately interpreted chest x-ray is the second line of investigation. However, non-quantitative litmus paper or the whoosh and blow tests are unreliable and should not be used.

New devices that track the passage of a magnetized tip of a nasogastric tube past the diaphragm are currently being evaluated. However, their role in confirming correct placement is not yet established. It is crucial to follow established protocols and guidelines to prevent the misplacement of NG tubes and ensure patient safety.

Pityriasis versicolor is a skin condition that results from an overgrowth of Malassezia yeast. It is prevalent among young people, particularly males, and causes multiple patches of skin discoloration, mainly on the trunk. The patches may appear pale brown, pink, or depigmented, especially in individuals with dark skin, and may also be mildly itchy and flaky. The condition is often triggered by exposure to humid, sunny environments. Treatment involves the use of topical antifungals such as ketoconazole shampoo.

Understanding Pityriasis Versicolor

Pityriasis versicolor, also known as tinea versicolor, is a fungal infection that affects the skin’s surface. It is caused by Malassezia furfur, which was previously known as Pityrosporum ovale. This condition is characterized by patches that are commonly found on the trunk area. These patches may appear hypopigmented, pink, or brown, and may become more noticeable after sun exposure. Scaling is also a common feature, and mild itching may occur.

Pityriasis versicolor can affect healthy individuals, but it may also occur in people with weakened immune systems, malnutrition, or Cushing’s syndrome. Treatment for this condition typically involves the use of topical antifungal agents. According to NICE Clinical Knowledge Summaries, ketoconazole shampoo is a cost-effective option for treating large areas. If topical treatment fails, alternative diagnoses should be considered, and oral itraconazole may be prescribed.

In summary, pityriasis versicolor is a fungal infection that affects the skin’s surface. It is characterized by patches that may appear hypopigmented, pink, or brown, and scaling is a common feature. Treatment typically involves the use of topical antifungal agents, and oral itraconazole may be prescribed if topical treatment fails.

The patient’s chronic use of analgesics for their lower back pain has resulted in tubulo-interstitial nephritis and papillary necrosis. This can cause the papillae to slough off and potentially obstruct the urinary tract, leading to acute kidney injury or chronic renal failure. Additionally, a low sodium level may be present due to a salt-losing nephropathy commonly associated with this condition.

Understanding Papillary Necrosis: Causes and Features

Papillary necrosis is a medical condition that affects the kidneys, specifically the renal papillae. This condition is characterized by the death of the cells in the renal papillae, which can lead to various complications. There are several causes of papillary necrosis, including chronic analgesia use, sickle cell disease, tuberculosis, acute pyelonephritis, and diabetes mellitus.

One of the most common causes of papillary necrosis is the chronic use of analgesics, particularly nonsteroidal anti-inflammatory drugs (NSAIDs). Sickle cell disease, which affects the shape of red blood cells, can also lead to papillary necrosis. Tuberculosis and acute pyelonephritis, which are both bacterial infections, can also cause this condition. Finally, diabetes mellitus, a chronic metabolic disorder, can also lead to papillary necrosis.

The features of papillary necrosis include fever, loin pain, and hematuria. These symptoms can be indicative of other medical conditions, so it is important to undergo diagnostic tests to confirm the presence of papillary necrosis. One such test is an intravenous urogram (IVU), which can show papillary necrosis with renal scarring, also known as cup and spill.

GHB, also known as ‘Grievous Bodily Harm’, is a substance that is tasteless, colorless, and odorless. It acts as a depressant on the central nervous system and is often abused for its ability to induce hypnosis, amnesia, and euphoria. It is commonly used by party-goers and has gained notoriety for its use as a date-rape drug.

The toxicity of GHB is caused by its effects as a CNS depressant. Symptoms of toxicity include vomiting, mild bradycardia, respiratory depression, and coma. The most notable feature of GHB toxicity is its short recovery time, with patients typically recovering within 6 hours. In some cases, patients have even been known to self-extubate in the Emergency Department.

Heroin and diazepam can produce similar symptoms, but recovery is typically more gradual. Naloxone is often used to reverse a heroin overdose.

Novel psychoactive substances are new drugs that are chemically related to established recreational drugs. They are often referred to as ‘legal highs’ but have been illegal in the UK since 2016. They can be stimulants, cannabinoids, hallucinogens, depressants, or other substances such as GHB and nitrous oxide. Adverse effects are similar to the original drug class.

Treatment Options for Pelvic Inflammatory Disease

Pelvic inflammatory disease (PID) is a common infection of the female reproductive system that can lead to serious complications if left untreated. The following are treatment options for PID:

Intramuscular ceftriaxone single dose, oral doxycycline and metronidazole for 14 days: This treatment provides microbiological cover for Neisseria gonorrhoeae and prevents the development of resistance to ceftriaxone. Metronidazole is included to improve coverage of anaerobic bacteria.

Oral ofloxacin with oral metronidazole for 14 days: This is a second-line therapy for PID.

Intravenous ceftriaxone and intravenous doxycycline for 14 days: This treatment is recommended for patients with severe PID.

Oral moxifloxacin for 14 days: This treatment alone is not recommended for PID.

Oral azithromycin single dose: Combination drug therapy is preferred for PID treatment.

Actinic keratosis can be effectively treated with topical 5-FU, imiquimod or diclofenac as a first line of defense. This patient’s symptoms are consistent with actinic keratosis, which is a type of sun-damaged skin that can develop into squamous cell carcinoma. Other treatment options include cryotherapy. However, hydrocortisone and emollients are used for eczema, while miconazole shampoo is used for treating tinea and other infections.

Actinic keratoses, also known as solar keratoses, are skin lesions that develop due to prolonged exposure to the sun. These lesions are typically small, crusty, and scaly, and can appear in various colors such as pink, red, brown, or the same color as the skin. They are commonly found on sun-exposed areas like the temples of the head, and multiple lesions may be present.

To manage actinic keratoses, prevention of further risk is crucial, such as avoiding sun exposure and using sun cream. Treatment options include a 2 to 3 week course of fluorouracil cream, which may cause redness and inflammation. Topical hydrocortisone may be given to help settle the inflammation. Topical diclofenac is another option for mild AKs, with moderate efficacy and fewer side-effects. Topical imiquimod has shown good efficacy in trials. Cryotherapy and curettage and cautery are also available as treatment options.

Diagnosis of a Craniopharyngioma

The most probable diagnosis for this patient is a craniopharyngioma, which is compressing the chiasm from above, leading to a bilateral inferior quadrantanopia. The patient’s history also suggests that there is some cavernous sinus extension, given the trigeminal nerve involvement, and compression of the pituitary stalk, leading to overproduction of prolactin. Additionally, the patient has experienced two recent temporal lobe seizures, indicating medial temporal lobe involvement.

Compared to other possible diagnoses, a pituitary adenoma is less likely to cause a bilateral inferior quadrantanopia initially, and one would expect to see signs or symptoms of pituitary dysfunction. A parietal tumor would cause a unilateral inferior quadrantanopia field defect, while Vigabatrin-associated field defects are typically nasal rather than temporal and would not explain the additional signs and symptoms in this patient. Glaucoma producing a marked field defect would be evident on fundoscopy.

In conclusion, the patient’s symptoms and history suggest a craniopharyngioma with cavernous sinus extension, leading to a bilateral inferior quadrantanopia and overproduction of prolactin. The patient’s recent temporal lobe seizures also indicate medial temporal lobe involvement.

Metformin is the correct answer. The patient in question has type 1 diabetes that is poorly controlled. Additionally, he is overweight and of Indian ethnicity. Due to the side effects, increasing insulin doses is not a popular option. NICE suggests that metformin may be a viable alternative to increasing insulin in overweight individuals of Indian origin. This is particularly beneficial as it would not result in further weight gain.

Understanding Insulin Therapy

Insulin therapy has been a game-changer in the management of diabetes mellitus since its development in the 1920s. It remains the only available treatment for type 1 diabetes mellitus (T1DM) and is widely used in type 2 diabetes mellitus (T2DM) when oral hypoglycemic agents fail to provide adequate control. However, understanding the different types of insulin can be overwhelming, and it is crucial to have a basic grasp to avoid potential harm to patients.

Insulin can be classified by manufacturing process, duration of action, and type of insulin analogues. Patients often require a combination of preparations to ensure stable glycemic control throughout the day. Rapid-acting insulin analogues act faster and have a shorter duration of action than soluble insulin and may be used as the bolus dose in ‘basal-bolus’ regimes. Short-acting insulins, such as Actrapid and Humulin S, may also be used as the bolus dose in ‘basal-bolus’ regimen. Intermediate-acting insulins, like isophane insulin, are often used in a premixed formulation with long-acting insulins, such as insulin determir and insulin glargine, given once or twice daily. Premixed preparations combine intermediate-acting insulin with either a rapid-acting insulin analogue or soluble insulin.

The vast majority of patients administer insulin subcutaneously, and it is essential to rotate injection sites to prevent lipodystrophy. Insulin pumps are available, which delivers a continuous basal infusion and a patient-activated bolus dose at meal times. Intravenous insulin is used for patients who are acutely unwell, such as those with diabetic ketoacidosis. Inhaled insulin is available but not widely used, and oral insulin analogues are in development but have considerable technical hurdles to clear. Overall, understanding insulin therapy is crucial for healthcare professionals to provide safe and effective care for patients with diabetes mellitus.

Antibiotics and Pregnancy: Risks and Recommendations

During pregnancy, certain antibiotics should be avoided due to potential risks to the developing fetus. Macrolide antibiotics, such as clarithromycin, are the preferred first-line agents for pneumonia in patients allergic to penicillin. However, in early pregnancy, the use of clarithromycin may be associated with early fetal loss. Quinolones, like ciprofloxacin, are not recommended for use in pregnancy due to the increased risk of tendon rupture in animal models and cartilage abnormalities. Tetracyclines, including doxycycline, are also not recommended due to the risk of significant and permanent tooth discoloration. Cephalosporins, like cephalexin, may be less effective than macrolides in treating pneumonia and have some crossover of allergy with penicillins. Even second-generation quinolones, like olfloxacin, are still associated with an increased risk of tendon rupture. It is important for pregnant women to discuss the risks and benefits of any medication with their healthcare provider before taking it.

The patient’s medical history of experiencing headaches accompanied by temporary visual disturbances, along with the results of their examination, suggest that they may be suffering from idiopathic intracranial hypertension (IIH). However, the fact that these symptoms began during the puerperium period, and that the patient is otherwise healthy and not at risk for IIH, raises concerns that they may actually be experiencing cerebral venous sinus thrombosis. Therefore, it is important to conduct imaging of the venous system using CT or MR to rule out a thrombus, which would require anticoagulation treatment.

While a therapeutic lumbar puncture can provide temporary relief for IIH-related headaches, it is not a long-term solution. In cases where medical management has failed, ventriculo-peritoneal shunting may be necessary.

Nerve conduction studies are not relevant to this patient’s condition. Additionally, since acetazolamide can cause paraesthesia as a side effect, increasing the dosage may not be a viable option for this patient.

Intracranial Venous Thrombosis: Causes, Symptoms, and Management

Intracranial venous thrombosis is a condition that can cause cerebral infarction, although it is less common than arterial causes. About 50% of patients have isolated sagittal sinus thromboses, while the remainder have coexistent lateral sinus thromboses and cavernous sinus thromboses. Common symptoms include sudden onset headache, nausea and vomiting, and reduced consciousness.

To diagnose intracranial venous thrombosis, MRI venography is the gold standard, although CT venography is an alternative. Non-contrast CT head is normal in around 70% of patients, and D-dimer levels may be elevated. The management of intracranial venous thrombosis involves anticoagulation, typically with low molecular weight heparin acutely, and warfarin for longer-term anticoagulation.

There are specific syndromes associated with intracranial venous thrombosis. Sagittal sinus thrombosis may present with seizures and hemiplegia, and parasagittal biparietal or bifrontal haemorrhagic infarctions are sometimes seen. Cavernous sinus thrombosis may cause periorbital oedema, ophthalmoplegia, trigeminal nerve involvement, and central retinal vein thrombosis. Lateral sinus thrombosis may cause 6th and 7th cranial nerve palsies.

In summary, intracranial venous thrombosis is a serious condition that requires prompt diagnosis and management. Patients with symptoms such as sudden onset headache, nausea and vomiting, and reduced consciousness should seek medical attention immediately. MRI venography is the gold standard for diagnosis, and anticoagulation is the mainstay of treatment. Specific syndromes associated with intracranial venous thrombosis may present with seizures, hemiplegia, ophthalmoplegia, and other symptoms.

IgA nephropathy, also known as Berger’s disease, is a type of glomerulonephritis that is characterized by persistent microscopic or recurrent macroscopic hematuria, often associated with upper respiratory tract infections. It is commonly linked to cirrhosis and coeliac disease, and elevated IgA levels are present in 50% of cases. Treatment is usually unnecessary unless renal function is affected, in which case an ACE inhibitor may be prescribed to control blood pressure. Immunotherapy has not been extensively studied. Dapsone, a medication used to treat leprosy and dermatitis herpetiformis, can cause hemolytic anemia and allergic reactions. Amyloidosis causes proteinuria and the nephrotic syndrome, while cryoglobulinemia is associated with hematological malignancies and connective tissue diseases and presents with cutaneous and articular manifestations. Renal cell carcinoma, which arises from the tubular epithelium, typically presents with painless hematuria and a palpable abdominal mass. For further information, refer to Lai K N et al.’s 2015 article on the treatment of IgA nephropathy in Kidney Disease (Basel).

The most appropriate medication for this patient is ganciclovir, as they are likely suffering from CMV pneumonitis. Prednisolone would be more suitable for treating PCP, heparin would be necessary if a pulmonary embolus was suspected, tazocin is a broad-spectrum antibiotic used for bacterial infections, and co-trimoxazole is the first-line treatment for PCP. Several factors strongly suggest that CMV is the cause of the infection, including fever with desaturation in poorly controlled HIV, evidence of retinitis, and a chest X-ray showing bilateral interstitial infiltrates. A biopsy or broncho-alveolar lavage can confirm the diagnosis using PCR to amplify CMV. The negative silver staining also makes PCP less likely.

Understanding Cytomegalovirus

Cytomegalovirus (CMV) is a type of herpes virus that is believed to have infected around 50% of the population. However, it usually only causes disease in individuals with weakened immune systems, such as those with HIV or those who have undergone organ transplantation and are taking immunosuppressants.

When cells are infected with CMV, they develop an Owl’s eye appearance due to the presence of intranuclear inclusion bodies. The virus can cause a range of diseases, including congenital CMV infection, CMV mononucleosis, CMV retinitis, CMV encephalopathy, CMV pneumonitis, and CMV colitis.

Congenital CMV infection can lead to growth retardation, microcephaly, sensorineural deafness, encephalitis, and hepatosplenomegaly. CMV mononucleosis can cause an illness similar to infectious mononucleosis in individuals with healthy immune systems. CMV retinitis is common in HIV patients with a low CD4 count and can cause visual impairment, retinal hemorrhages, and necrosis. CMV encephalopathy and CMV pneumonitis can also occur in individuals with HIV who have low CD4 counts.

Overall, understanding CMV and its potential effects is important for individuals with weakened immune systems and healthcare professionals who treat them.

The patient is displaying typical symptoms of giardiasis, which is commonly contracted through domestic exposure rather than travel. Despite initial treatment being unsuccessful, a repeat course of antibiotics (metronidazole or tinidazole) is recommended. The patient has taken measures to avoid reinfection by changing her job temporarily. It’s important to note that giardiasis can cause temporary lactose intolerance, leading to ongoing gastrointestinal symptoms even after the infection is gone. Patients should avoid dairy products for 2-6 weeks to rule out this possibility. If an individual has risk factors for Giardia infection and symptoms similar to irritable bowel syndrome, faecal testing for ova and parasites should be considered to exclude giardiasis. However, in this case, the patient’s lack of previous gastrointestinal symptoms makes a diagnosis of irritable bowel syndrome unlikely.

Understanding Giardiasis

Giardiasis is a disease caused by a type of protozoan called Giardia lamblia. It is transmitted through the faeco-oral route and can be contracted through various means such as foreign travel, drinking water from rivers or lakes, and even male-male sexual contact. While some people may not experience any symptoms, others may suffer from non-bloody diarrhea, bloating, abdominal pain, lethargy, flatulence, and weight loss. In some cases, malabsorption and lactose intolerance may also occur. To diagnose giardiasis, stool microscopy for trophozoite and cysts is usually done, although stool antigen detection assay and PCR assays are also being developed. Treatment for giardiasis involves the use of metronidazole.

Hyponatraemia can be corrected rapidly with saline, but this can lead to central pontine myelinolysis (CPM). CPM can cause a range of symptoms, but the most common are spastic quadriparesis, pseudobulbar palsy, and emotional lability (pseudobulbar affect).

In this case, the patient had severe hypovolaemic hyponatraemia due to diarrhoea. The administration of large amounts of saline resulted in a rapid correction of the hyponatraemia, which caused a sudden increase in plasma osmolarity. This shift in fluids from the cerebral intracellular space to the extravascular space can cause the brain to shrink and demyelinate, leading to CPM.

Hyponatremia is a condition where the sodium levels in the blood are too low. If left untreated, it can lead to cerebral edema and brain herniation. Therefore, it is important to identify and treat hyponatremia promptly. The treatment plan depends on various factors such as the duration and severity of hyponatremia, symptoms, and the suspected cause. Over-rapid correction can lead to osmotic demyelination syndrome, which is a serious complication.

Initial steps in treating hyponatremia involve ruling out any errors in the test results and reviewing medications that may cause hyponatremia. For chronic hyponatremia without severe symptoms, the treatment plan varies based on the suspected cause. If it is hypovolemic, normal saline may be given as a trial. If it is euvolemic, fluid restriction and medications such as demeclocycline or vaptans may be considered. If it is hypervolemic, fluid restriction and loop diuretics or vaptans may be considered.

For acute hyponatremia with severe symptoms, patients require close monitoring in a hospital setting. Hypertonic saline is used to correct the sodium levels more quickly than in chronic cases. Vaptans, which act on V2 receptors, can be used but should be avoided in patients with hypovolemic hyponatremia and those with underlying liver disease.

It is important to avoid over-correction of severe hyponatremia as it can lead to osmotic demyelination syndrome. Symptoms of this condition include dysarthria, dysphagia, paralysis, seizures, confusion, and coma. Therefore, sodium levels should only be raised by 4 to 6 mmol/L in a 24-hour period to prevent this complication.

Medications for Nausea in Young Women

When treating nausea in young women, it is important to avoid medications that may cause acute dystonic reactions. Metoclopramide and prochlorperazine are not recommended due to their association with spasmodic torticollis, trismus, and oculogyric crises. However, if these medications are administered and acute dystonia occurs, procyclidine can be given as an anti-cholinergic agent to promptly alleviate symptoms. It is also important to avoid medications from the same group in the future.

Domperidone is a better option as it is a peripherally selective D2 receptor antagonist and is less likely to cause acute dystonic reactions. Ondansetron is another option as it is a 5HT antagonist that can treat nausea without the risk of causing acute dystonia.

Sumatriptan is used for migraine intervention and is a 5HT agonist, but it is not recommended for the treatment of nausea in young women. It is important to carefully consider the potential side effects of medications when treating nausea in this patient group.

To manage breakthrough pain, it is recommended to administer a dose of alfentanil that is equivalent to 1/6th of the daily morphine dose. This is in line with palliative care guidelines. Alfentanil is a highly effective medication, especially for patients with renal failure, as it is metabolized by the liver, has no active metabolites, and has a short half-life.

Palliative care prescribing for pain is guided by NICE and SIGN guidelines. NICE recommends starting with regular oral modified-release or immediate-release morphine, with immediate-release morphine for breakthrough pain. Laxatives should be prescribed for all patients initiating strong opioids, and antiemetics should be offered if nausea persists. Drowsiness is usually transient, but if it persists, the dose should be adjusted. SIGN advises that the breakthrough dose of morphine is one-sixth the daily dose, and all patients receiving opioids should be prescribed a laxative. Opioids should be used with caution in patients with chronic kidney disease, and oxycodone is preferred to morphine in patients with mild-moderate renal impairment. Metastatic bone pain may respond to strong opioids, bisphosphonates, or radiotherapy, and all patients should be considered for referral to a clinical oncologist for further treatment. When increasing the dose of opioids, the next dose should be increased by 30-50%. Conversion factors between opioids are also provided. Opioid side-effects include nausea, drowsiness, and constipation, which are usually transient but may persist. Denosumab may be used to treat metastatic bone pain in addition to strong opioids, bisphosphonates, and radiotherapy.

Abetalipoproteinemia is a rare genetic disorder that is caused by a mutation in the microsomal triglyceride transfer protein. This mutation leads to a deficiency in apolipoproteins, which are essential for the synthesis and exportation of chylomicrons and VLDL. As a result, individuals with this condition experience malabsorption of dietary fats, cholesterol, and fat-soluble vitamins such as vitamins K, A, D, and E. Symptoms of abetalipoproteinemia include steatorrhea, poor growth, neurological dysfunction, and impaired vision. The recommended treatment for this condition involves restricting dietary fat intake and administering high doses of vitamin E.

Abetalipoproteinemia: A Rare Genetic Disorder

Abetalipoproteinemia is a genetic disorder that is inherited in an autosomal recessive pattern. It is caused by a mutation in the microsomal triglyceride transfer protein, which leads to a deficiency in the apolipoproteins B-48 and B-100. This rare disorder is characterized by several symptoms, including failure to thrive and developmental delay, steatorrhoea, retinitis pigmentosa, cerebellar signs, absent deep tendon reflexes, acanthocytosis, and hypocholesterolaemia.

Individuals with abetalipoproteinemia may experience difficulty gaining weight and growing properly, as well as delays in reaching developmental milestones. They may also have problems with digestion, as their bodies are unable to properly absorb fats from their diet, leading to steatorrhoea. In addition, they may experience vision problems due to retinitis pigmentosa, a condition that causes progressive degeneration of the retina. Cerebellar signs, such as poor coordination and balance, may also be present.

Diagnosis of abetalipoproteinemia is typically made through genetic testing, as well as through the presence of characteristic symptoms. Treatment may involve dietary changes to manage steatorrhoea, as well as vitamin supplements to address deficiencies. While there is no cure for abetalipoproteinemia, early diagnosis and management can help improve outcomes for affected individuals.

Numerous trials have shown that dexamethasone is the most effective agent in preventing delayed nausea and vomiting caused by chemotherapy. While antiemetics are useful in reducing immediate nausea and vomiting, they are not as effective in the delayed phase, which occurs between 24 hours and 1 week after chemotherapy. Levopromazine is a potent antiemetic but is reserved for palliative care due to its sedative effects. Lorazepam has mild antiemetic properties and is primarily used for its anti-anxiolytic effects. Metoclopramide is an effective antiemetic for immediate nausea and vomiting but is not as useful as dexamethasone in the delayed phase.

Managing Nausea and Vomiting as Side-Effects of Chemotherapy

Chemotherapy is a common treatment for cancer, but it often comes with side-effects such as nausea and vomiting. These symptoms can be triggered by various factors, including anxiety, age, concurrent use of opioids, and the type of chemotherapy used. Patients who are at low-risk of developing these symptoms may be prescribed drugs like metoclopramide as a first-line treatment. However, for high-risk patients, 5HT3 receptor antagonists like ondansetron are often more effective, especially when combined with dexamethasone.

To manage nausea and vomiting, it is important to identify the risk factors and choose the appropriate medication. Patients should also be advised to eat small, frequent meals and avoid foods that trigger their symptoms. Additionally, relaxation techniques such as deep breathing and meditation may help reduce anxiety and prevent nausea and vomiting. With proper management, patients can minimize the impact of these side-effects and focus on their recovery.

If a woman has hypothyroidism, it is recommended to promptly raise the dosage of levothyroxine and closely observe her TSH levels.

Managing Hypothyroidism: Dosage, Goals, and Side-Effects

Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormone. The management of hypothyroidism involves the use of levothyroxine, a synthetic form of thyroid hormone. The initial starting dose of levothyroxine should be lower in elderly patients and those with ischaemic heart disease. For patients with cardiac disease, severe hypothyroidism, or patients over 50 years, the initial starting dose should be 25 mcg od with dose slowly titrated. Other patients should be started on a dose of 50-100 mcg od. After a change in thyroxine dose, thyroid function tests should be checked after 8-12 weeks. The therapeutic goal is to achieve a ‘normalisation’ of the thyroid stimulating hormone (TSH) level, with a TSH value of 0.5-2.5 mU/l being the preferred range.

Women with established hypothyroidism who become pregnant should have their dose increased ‘by at least 25-50 micrograms levothyroxine’* due to the increased demands of pregnancy. The TSH should be monitored carefully, aiming for a low-normal value. There is no evidence to support combination therapy with levothyroxine and liothyronine.

Levothyroxine therapy may cause side-effects such as hyperthyroidism due to over-treatment, reduced bone mineral density, worsening of angina, and atrial fibrillation. Interactions with iron and calcium carbonate may reduce the absorption of levothyroxine, so they should be given at least 4 hours apart.

In summary, the management of hypothyroidism involves careful dosage adjustment, regular monitoring of thyroid function tests, and aiming for a TSH value in the normal range. Women who become pregnant should have their dose increased, and combination therapy with levothyroxine and liothyronine is not recommended. Patients should also be aware of potential side-effects and interactions with other medications.

*source: NICE Clinical Knowledge Summaries

Based on the plasma and urine osmolality results, it appears that the patient’s renal response to ADH is normal. Therefore, the most probable cause of the patient’s polydipsia is primary polydipsia. The incorrect stems suggesting SIADH or diabetes insipidus caused by certain drugs are not supported by the test results. Additionally, there are no indications of other biochemical causes such as diuretic medication, diabetes mellitus, hyperthyroidism, or electrolyte abnormalities. Although lithium therapy can cause polydipsia, the patient’s sub-therapeutic serum levels make this unlikely. Furthermore, there is no history of excessive alcohol consumption.

Polyuria, or excessive urination, can be caused by a variety of factors. A recent review in the BMJ categorizes these causes by their frequency of occurrence. The most common causes of polyuria include the use of diuretics, caffeine, and alcohol, as well as diabetes mellitus, lithium, and heart failure. Less common causes include hypercalcaemia and hyperthyroidism, while rare causes include chronic renal failure, primary polydipsia, and hypokalaemia. The least common cause of polyuria is diabetes insipidus, which occurs in less than 1 in 10,000 cases. It is important to note that while these frequencies may not align with exam questions, understanding the potential causes of polyuria can aid in diagnosis and treatment.

Management of Severe Colitis in a Patient on Immune Checkpoint Inhibitor Therapy

A patient presents with severe colitis, most likely an adverse reaction to their second-line treatment with an immune checkpoint inhibitor (ICI). Treatment involves high-dose parenteral corticosteroids, with specialist opinions sought early as some cases may be steroid-refractory and require second-line therapy with anti-tumour necrosis factor (anti-TNF) agents. An urgent flexisigmoidoscopy should be organized to obtain histological samples and exclude alternative pathology. Antibiotics are not routinely administered in diarrhoea of presumptive infectious aetiology, and fluoroquinolones such as ciprofloxacin should be used with caution due to potential adverse drug reactions. Conservative management with fluid resuscitation and electrolyte replacement can help with acute kidney disease and hypokalaemia secondary to gastrointestinal losses. Oral steroids may be an option for less severe immunotherapy-related colitis, but in severe cases, inpatient admission is warranted. There is no indication for oral vancomycin and metronidazole as there are no risk factors for C. difficile infection.

Vitamin B12 Deficiency and Subacute Cord Degeneration

Examination results indicate that the patient is experiencing a spastic paraparesis with a peripheral neuropathy affecting the dorsal column. However, spinothalamic sensory examination appears normal. These clinical findings are consistent with subacute cord degeneration and peripheral neuropathy caused by a deficiency in vitamin B12. MRI scans reveal that the demyelination process primarily affects the lower cervical and upper thoracic regions of the dorsal columns, but may eventually spread throughout the entire area.

The patient has a history of autoimmune endocrinopathies, and pernicious anaemia is the most likely cause of the vitamin B12 deficiency. It is important to address this deficiency promptly, as it can lead to irreversible neurological damage if left untreated.

Coagulation Abnormalities in Severe Sepsis

Severe sepsis can lead to disseminated intravascular coagulation (DIC), which is a condition where blood clots form throughout the body, leading to organ damage and bleeding. The most likely source of sepsis in this case is the urinary tract.

In severe sepsis, several coagulation abnormalities may be observed. The activated partial thromboplastin time (APTT) and prothrombin time (PT) are typically elevated, indicating a delay in blood clotting. The levels of fibrin degradation products (FDPs) and D-dimers, which are markers of blood clot breakdown, are also elevated. Platelet counts are reduced, which can further contribute to bleeding. Additionally, levels of protein C and antithrombin, which are natural anticoagulants, are reduced, further exacerbating the coagulation abnormalities.

Overall, these coagulation abnormalities can contribute to the development of DIC and worsen the prognosis of sepsis. Early recognition and treatment of sepsis are crucial in preventing the development of DIC and improving patient outcomes.

Osteoporosis in Klinefelter’s Syndrome

Individuals with Klinefelter’s syndrome may experience osteoporosis due to testosterone deficiency. Testosterone replacement therapy is the most effective initial management option for this condition. While treatments such as alendronate, calcium and vitamin D, denosumab, and teriparatide are commonly used for patients at high risk of osteoporosis, they may not address the primary defect causing osteoporosis in Klinefelter’s syndrome. Therefore, testosterone replacement therapy should be considered as the first-line treatment for individuals with this condition. Adequate management of osteoporosis in Klinefelter’s syndrome can significantly reduce the risk of fractures and improve overall quality of life.

Ethylene glycol poisoning can cause a metabolic acidosis with a high anion gap and high osmolar gap. This is due to the toxic metabolites produced by the compound. Ethylene glycol is commonly found in automotive products and solvents, and is metabolized by alcohol dehydrogenase. Ethanol can inhibit this process, delaying the formation of toxic metabolites. Clinical findings such as oliguria, hematuria, and flank pain can help differentiate ethylene glycol toxicity from other toxic alcohols. The anion gap and osmolar gap can be calculated to aid in diagnosis.

Ethylene glycol is a type of alcohol that is commonly used as a coolant or antifreeze. The toxicity of this substance is divided into three stages. In the first stage, symptoms are similar to alcohol intoxication, such as confusion, slurred speech, and dizziness. The second stage is characterized by metabolic acidosis with a high anion gap and high osmolar gap, as well as tachycardia and hypertension. The third stage involves acute kidney injury.

In recent times, the management of ethylene glycol toxicity has changed. Ethanol has been used for many years, as it competes with ethylene glycol for the enzyme alcohol dehydrogenase. This limits the formation of toxic metabolites, such as glycolaldehyde and glycolic acid, which are responsible for the haemodynamic and metabolic features of poisoning. However, fomepizole, an inhibitor of alcohol dehydrogenase, is now used as a first-line treatment in preference to ethanol. In refractory cases, haemodialysis also has a role to play.

Diagnosis of Chronic Pancreatitis

The combination of steatorrhoea, diabetes, and excessive alcohol intake strongly suggest chronic pancreatitis as the diagnosis. The presence of malabsorption is only seen in moderate to advanced stages of the disease, which can be confirmed through a CT scan of the abdomen. However, a normal scan does not rule out the diagnosis, especially in early stages. The description of pain is also consistent with chronic pancreatitis.

While malabsorption and autoimmune disease (diabetes) are indicative of coeliac disease, abdominal pain is not a typical symptom. Tests such as 72-hour faecal fat estimation and D-xylose absorption testing can indicate the presence of malabsorption, but they are not diagnostic of an underlying condition. Upper gastrointestinal endoscopy and biopsy are useful in diagnosing small bowel conditions, but they cannot facilitate biopsy of the pancreas. Endoscopic ultrasound is the best modality for imaging the morphological changes of chronic pancreatitis and for facilitating biopsy.

Differential Diagnosis for a Patient with Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma is a common cancer in southern China, typically presenting with locally advanced disease. The primary pathologic cause of this squamous cell cancer is Epstein-Barr virus. When considering a differential diagnosis for a patient with nasopharyngeal carcinoma, it is important to rule out other potential causes.

Burkitt lymphoma is a type of cancer that often presents with jaw or facial tumors, but can also involve lymph nodes. However, the patient’s ethnicity, normal lactate dehydrogenase and uric acid concentration, and lack of history or evidence of immunosuppression make Burkitt lymphoma unlikely.

Hodgkin’s lymphoma typically presents with asymptomatic lymphadenopathy or a mediastinal mass on chest radiograph. However, the patient’s age, ethnicity, and tumor location make Hodgkin’s lymphoma an unlikely diagnosis.

Plasmacytoma with lymphadenopathy, normal blood counts, and normal calcium is uncommon. Mucor infection with no fevers or no history of immunosuppression is also uncommon.

In summary, when considering a differential diagnosis for a patient with nasopharyngeal carcinoma, it is important to rule out other potential causes such as Burkitt lymphoma, Hodgkin’s lymphoma, plasmacytoma, and mucor infection.

Thyroid Cancer and Graves’ Disease

This woman has hyperthyroidism and a cold nodule on uptake scanning, which strongly suggests thyroid carcinoma. The most likely diagnosis is Graves’ disease, which is characterized by periorbital puffiness and a thyroid bruit, and is often associated with papillary thyroid carcinoma. While thyroid cancer associated with Graves’ disease is not uncommon, it is important to consider this possibility in cases of suspicious or expanding nodules, rather than attributing them solely to Graves’ disease. In fact, more than 70% of cases of Graves’ disease are associated with thyroid peroxidase antibodies. Therefore, it is important to carefully evaluate any nodules in patients with Graves’ disease to ensure timely diagnosis and treatment of any potential thyroid cancer.

Diagnosis and Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion

The most likely diagnosis for a patient with low sodium levels is a syndrome of inappropriate antidiuretic hormone (SIADH) secretion. This condition is often caused by psychiatric medications, particularly antipsychotics like haloperidol, quetiapine, and clozapine. However, raising serum sodium levels too quickly can lead to central pontine myelinolysis, so caution must be exercised. Fluid restriction is the first step in treatment, with ADH antagonists like tolvaptan and demeclocyline reserved for more severe cases.

It is important to note that the patient has not experienced any seizures, but her low sodium levels still require attention. As the patient appears to have enough fluids in her body, administering saline is not the correct initial move. Instead, the problem is due to an excess of free body water, so the first step is to restrict fluid intake. By doing so, the patient’s sodium levels can be gradually increased without risking any further complications.